治療注射劑：設備、產品、市場

本報告研究了注射治療產品市場，並提供了市場概況、細分趨勢、新興技術趨勢、市場預測以及進入市場的公司概況。

內容

執行摘要

• 市場機會
• 配送市場動態
• 注射藥物的經濟學
• 推動注射裝置增長的因素
• 預充式註射器快速增長
• 預灌封注射器供應鏈
• 自我管理的傾向
• 人口統計數據的變化
• 一次性設備設計的創新
• 生物製劑的流行程度
• 治療性單克隆抗體
• 風險因素
• 注射裝置概要
• 自動注射器

單次固定劑量

可變劑量

雙室

無線自動注射器

• BETACONNECT（拜耳）
• RebiSmart（默克雪蘭諾）

主要產品

自動注射器

自動注射裝置設計元素

• 材料選擇問題
• 零件數量和設備成本
• 安全功能
• 針插入深度
• 故障保護激活
• 產能檢查/注入確認

市場因素

• 凍乾藥物/重構
• 人體工程學/人體工程學

筆式註射器

商業筆產品

甲狀旁腺激素

• 福特奧彭
• Pretact/Preos
• 納帕拉

生殖激素

• Foristim/Pure Gonpen
• 戈納列夫

可穿戴設備 - 分析和評估

新興技術

• 無線數據

注射劑市場分析及預測

• 自身免疫性疾病
  • 類風濕性關節炎
  • 牛皮癬
  • 多發性硬化症
• 造血作用
  • 荷爾蒙
  • 骨質疏鬆症
  • 生育能力

市場因素

• 監管問題
• 設備品牌
• 患者的依從性和可用性
• 醫療保健經濟學

公司簡介

“Therapeutic Injectable Drug: Devices, Products and Markets” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for therapeutic injectable drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

What You Will Learn:

• Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.

• Assesses key markets, market dynamics and market demographics.

• Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.

• Provides market data and forecasts.

• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations

• Assesses the importance of alliances and partnerships on drug product commercialization.

• Evaluates the impact of economic, technology, and regulatory factors.

Table of Contents

Executive Summary

• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Prefilled Syringe Supply Chain
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs
• Proliferation of Biological Drugs
• Therapeutic Monoclonal Antibodies
• Risk Factors
• Injectable Drug Device Summaries
• Autoinjectors

Single Fixed Dose

• Molly (SHL Medical)
• Molly RNS (SHLMedical)
• Bertha (SHL Medical)
• Maggie (SHL Medical)
• Amber (SHL Medical)
• AutoJect 2 (Owen Mumford)
• SelfDose (West Pharmaceutical Services)
• DAI (SHL Medical)
• DI 2 (SHL medical)
• Flexi-Q PFS (Elcam Medical)
• Physioject (Becton DIckinson
• Intevia (Becton Dickinson)

Variable Dosing

• VSDI + NIT
• Ypsomed VarioJect
• High Viscosity
• Rotaject Technology (SHL Medical)
• Ypsomed/Ypsomed 2.25)
• Flexi-Q HV (Elcam Medical)

Dual Chamber

Wirelessly Enabled Autoinjectors

• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)

Selected Product Specific

Autoinjectors

• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)

Autoinjector Device Design Factors

• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation

Market Factors

• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics

Pen Injectors

• Pen Injector Design Selection Factors
• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• Custom Pen Designs
• Reusable Pens
• Dual Chamber Pens

Commercial Pen Products

• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo (Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)

Parathyroid Hormone

• Forteo Pen
• Preotact/Preos
• Natpara

Reproductive Hormones

• Follistim/Puregon Pen
• Gonal-f

Wearable Devices - Analysis and Assessments

• Libertas (Becton Dickinson)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• eLVD Patch Pump (Elcam)

Emerging Technology

• Wireless Data

Injectable Drug Market Analysis and Forecasts

• Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis

• Hematopoietics
  • Hormones
  • Osteoporosis
  • Fertility

Market Factors

• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics

Company Profiles